Clinical Study

A Randomized, Placebo-Controlled, Parallel Group Study To Evaluate The Effect Of Amifampridine Phosphate In Patients With Musk Antibody Positive Myast

Posted Date: May 15, 2019

  • Investigator: Hani Kushlaf
  • Specialties:
  • Type of Study: Drug

MuSK (MSK-002 Randomized)

Criteria:

? Must Have Documented, Confirmed Diagnosis Of Mg ? Must Be Reasonably Willing And Able To Follow

Keywords:

Achr Antibody Positi, Musk Antibody Positi, Myasthenia Gravis

For More Information:

Molly Winters
513-558-0269
molly.winters@uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.